Press & News

Shortcuts:2009 2008 2007 2005 2004 2003 2002 2001
2009
•	University of Miami announces successful completion of safety phase of autologous stem cells in Transendocardial Autologous Cells in Heart Failure Trial (TAC-HFT); sixty patient randomized portion of trial has been initiated
•	TABMMI Heart Failure Stem Cell Clinical Trial Results Presented; Improvements Sustained at Three Year Follow-up
•	Novel UM Stem Cell Trial Completes Early Safety Phase
2008
•	TAC-HFT Stem Cell Trial Treats First Heart Failure Patient
•	Stem Cell Researchers At UM Enrolling Patients In Heart Failure Study - Catheter Injection System To Be Used
•	BioCardia and the University of Miami Receive FDA Clearance to Initiate Co-Sponsored Heart Failure Stem Cell Clinical Trial Comparing Two Cell Populations
•	BioCardia Completes $7.4 Million Private Equity Financing Successful Round Follows Completion of Phase I Clinical Trial Enrollment and Two Year Follow-up Data Publication on First Cohort
•	BioCardia announces completion of enrollment of TABMMI cardiac stem cell trial
2007
•	BioCardia announces completion of two year follow-up for patients enrolled in the TABMMI trial
•	BioCardia announces peer reviewed publication of one year follow-up data for stem cell clinical trial to treat chronic heart disease
2005
•	BioCardia announces completion of enrollment for Phase I adult stem cell clinical trial to treat chronic heart disease
•	BioCardia, Inc. and Symphony Medical, Inc. announce a mutually exclusive agreement for development and commercialization of a combination product that combines Symphony Medical's biotherapeutic technology and BioCardia device delivery technology for the treatment of cardiac conduction disorders
2004
•	BioCardia announces issuance of two patents on biotherapeutic delivery to the heart
•	BioCardia announces issuance of patents related to cell and gene therapy and drug eluting stents
•	Thoratec Corporation Announces Equity Investment in Emerging Heart Failure Technology - BioCardia Is Developing Tools for Delivery of Biotherapeutic Compounds to the Heart
•	Featured in "Convergence and Complexity in Cardiac Regeneration" START UP, April 2004
2003
•	Featured in "Cardiac Gene Therapy: Combination Products Next Frontier?"
2002
•	BioCardia Announces License Agreement with SRTI
2001
•	BioCardia Announces Important Patent on Catheter Drug Delivery to the Heart